Doctors at the Taipei Medical University Hospital (TMUH) were cautiously optimistic about the cryotherapy technology the university imported last year to treat patients suffering from inoperable liver cancer.
TMUH is the only hospital in Taiwan using an argon-helium "knife," Huang Ming-de (黃銘德) said during a press conference at the hospital.
Since importing the machine in March last year, almost thirty patients have undergone the less-invasive treatment. Either in conjunction with traditional surgery or through "keyhole surgery" performed with a laparoscope, the argon-helium knife works by freezing the tumor with a blast of liquid argon-helium gas.
"We can destroy an area of up to 8cm in diameter, cooling the tumor to as much as minus 260oC," Huang said. "Once the knife is withdrawn, the tumor shatters upon exposure to body heat."
"It is not for everyone and it is not a miracle cure," he said. "But it is another item in our arsenal against liver cancer," adding that surgical excision is still the preferred treatment.
Seventy percent to 80 percent of lung cancer patients are ineligible for surgery, however, because of tumors that are too big or the presence of too many cancerous sites.
"Studies abroad seem to indicate that in suitable patients, cryoknife surgery might extend life by one year to 33 months," he said.
A point in favor of the therapy is that its intrusiveness is minimal, Huang said.
A 67-year-old woman whose breast cancer metastasized to her liver was able to leave the hospital the same day she received argon-helium knife therapy, he said.
"The woman refused an operation to remove the tumor on her liver because she had gone through so many surgeries and chemotherapy treatments already," Huang said. "But we were able to convince her to [try] cryotherapy."
The woman underwent the procedure three months ago, Huang said.
The treatment is not covered by the National Health Insurance and the woman had to pay NT$70,000 for the treatment, including anes-thesiology costs.
"It is too early to tell if the tumor will return," Huang said.
"But the patient's quality of life has increased and she was able to diminish use of chemotherapy medication and even go on a holiday to China," he said.
South Korean K-pop girl group Blackpink are to make Kaohsiung the first stop on their Asia tour when they perform at Kaohsiung National Stadium on Oct. 18 and 19, the event organizer said yesterday. The upcoming performances will also make Blackpink the first girl group ever to perform twice at the stadium. It will be the group’s third visit to Taiwan to stage a concert. The last time Blackpink held a concert in the city was in March 2023. Their first concert in Taiwan was on March 3, 2019, at NTSU Arena (Linkou Arena). The group’s 2022-2023 “Born Pink” tour set a
CPBL players, cheerleaders and officials pose at a news conference in Taipei yesterday announcing the upcoming All-Star Game. This year’s CPBL All-Star Weekend is to be held at the Taipei Dome on July 19 and 20.
The Taiwan High Court yesterday upheld a lower court’s decision that ruled in favor of former president Tsai Ing-wen (蔡英文) regarding the legitimacy of her doctoral degree. The issue surrounding Tsai’s academic credentials was raised by former political talk show host Dennis Peng (彭文正) in a Facebook post in June 2019, when Tsai was seeking re-election. Peng has repeatedly accused Tsai of never completing her doctoral dissertation to get a doctoral degree in law from the London School of Economics and Political Science (LSE) in 1984. He subsequently filed a declaratory action charging that
The Hualien Branch of the High Court today sentenced the main suspect in the 2021 fatal derailment of the Taroko Express to 12 years and six months in jail in the second trial of the suspect for his role in Taiwan’s deadliest train crash. Lee Yi-hsiang (李義祥), the driver of a crane truck that fell onto the tracks and which the the Taiwan Railways Administration's (TRA) train crashed into in an accident that killed 49 people and injured 200, was sentenced to seven years and 10 months in the first trial by the Hualien District Court in 2022. Hoa Van Hao, a